INLEXZO vs XELODA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. INLEXZO and XELODA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	INLEXZO	XELODA
Rating	New	New
Pharmacy pays	~$599.88 /30	~$14.21 /30
Type	RX	RX
Active ingredient	GEMCITABINE HYDROCHLORIDE	CAPECITABINE
Manufacturer	Janssen Biotech	Cheplapharm
Dosage forms	System	Tablet
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	Boxed warning
Treats	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms	Breast Neoplasms, Colorectal Neoplasms

inlexzo xeloda

Rating

New

Pharmacy pays

~$599.88 /30

~$14.21 /30

Type

Active ingredient

GEMCITABINE HYDROCHLORIDE

CAPECITABINE

Manufacturer

Janssen Biotech

Cheplapharm

Dosage forms

System

Tablet

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Boxed warning

Treats

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

Breast Neoplasms, Colorectal Neoplasms

Frequently asked questions

Which is cheaper, Inlexzo or Xeloda?

Xeloda costs pharmacies less to acquire — about $14.21 vs $599.88 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Inlexzo and Xeloda?

Inlexzo contains Gemcitabine Hydrochloride, while Xeloda contains Capecitabine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.